Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription


1 Ann Neurol
1 BMC Neurol
1 Int J Clin Pract
3 J Autoimmun
3 J Immunol
4 J Neuroimmunol
2 J Rheumatol
1 Lancet Neurol
6 Mult Scler
1 N Engl J Med
3 Neurology
2 PLoS One
1 Proc Natl Acad Sci U S A

    Ann Neurol

    Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision-Making.
    Ann Neurol. 2021;89:1084-1087.
    >> Share

    BMC Neurol

  2. ALLUQMANI M, Roda W, Qqrmli M, Blevins G, et al
    Differential disease phenotypes and progression in relapsing-remitting multiple sclerosis: comparative analyses of single Canadian and Saudi Arabian clinics.
    BMC Neurol. 2021;21:295.
    >> Share

    Int J Clin Pract

  3. UZKESER H, Keskin H, Haliloglu S, Cayir Y, et al
    Is Mean Platelet Volume Related to Disease Activity in Systemic Lupus Erythematosus?
    Int J Clin Pract. 2021 Jul 29:e14676. doi: 10.1111/ijcp.14676.
    >> Share

    J Autoimmun

  4. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    >> Share

  5. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    >> Share

  6. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    >> Share

    J Immunol

  7. PERRY DJ, Peters LD, Lakshmi PS, Zhang L, et al
    Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4(+) T Cell Activation.
    J Immunol. 2021;207:849-859.
    >> Share

  8. THOMSON AS, Mai SH, Bouma G, Herdman M, et al
    Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity.
    J Immunol. 2021;206:1067-1076.
    >> Share

  9. CHEN L, Bai J, Peng D, Gao Y, et al
    SZB120 Exhibits Immunomodulatory Effects by Targeting eIF2alpha to Suppress Th17 Cell Differentiation.
    J Immunol. 2021;206:953-962.
    >> Share

    J Neuroimmunol

  10. LOCKHART A, Boers P
    Paraneoplastic neurologic syndromes with multiple neural autoantibodies: A report of two cases.
    J Neuroimmunol. 2021;358:577665.
    >> Share

  11. YAO Y, Li X, Lin J, Zhang X, et al
    Thymoma-associated autoimmune encephalitis with positive Titin antibodies: A case report.
    J Neuroimmunol. 2021;358:577670.
    >> Share

  12. WANG J, Yan C, Zhao Z, Chen H, et al
    Sexual dysfunction in patients with myasthenia gravis.
    J Neuroimmunol. 2021;358:577669.
    >> Share

  13. CAPARO-ZAMALLOA C, Alvarez-Toledo K, Yamunaque-Chunga C, Castro-Suarez S, et al
    Autoimmune neurology: Co-occurrence of anti-NMDAR encephalitis and anti-MOG associated disease, report of a case.
    J Neuroimmunol. 2021;358:577663.
    >> Share

    J Rheumatol

  14. AL AWQATI MZ, Sluzevich JC, Berianu F
    Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-gamma Antibody.
    J Rheumatol. 2021 Jun 15. pii: jrheum.200399. doi: 10.3899/jrheum.200399.
    >> Share

    Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210024. doi: 10.3899/jrheum.210024.
    >> Share

    Lancet Neurol

  16. KIRA JI
    Redefining use of MRI for patients with multiple sclerosis.
    Lancet Neurol. 2021;20:591-592.
    >> Share

    Mult Scler

  17. SORMANI MP, Schiavetti I, Landi D, Carmisciano L, et al
    SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
    Mult Scler. 2021 Jul 30:13524585211035318. doi: 10.1177/13524585211035318.
    >> Share

  18. ROTSTEIN D, Maxwell C, Tu K, Gatley J, et al
    High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
    Mult Scler. 2021 Jul 30:13524585211031791. doi: 10.1177/13524585211031791.
    >> Share

  19. PITTERI M, Magliozzi R, Nicholas R, Ziccardi S, et al
    Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients.
    Mult Scler. 2021 Jul 30:13524585211032510. doi: 10.1177/13524585211032510.
    >> Share

  20. UHR L, Mateen FJ
    COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey.
    Mult Scler. 2021 Jul 27:13524585211030647. doi: 10.1177/13524585211030647.
    >> Share

  21. LAURSON-DOUBE J, Rijke N, Helme A, Baneke P, et al
    Ethical use of off-label disease-modifying therapies for multiple sclerosis.
    Mult Scler. 2021 Jul 26:13524585211030207. doi: 10.1177/13524585211030207.
    >> Share

  22. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis.
    Mult Scler. 2021 Jul 26:13524585211031801. doi: 10.1177/13524585211031801.
    >> Share

    N Engl J Med

    One Hundred Years of Insulin for Some.
    N Engl J Med. 2021;385:293-295.
    >> Share


  24. AKAISHI T, Takahashi T, Misu T, Kaneko K, et al
    Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2021;97:e1-e12.
    >> Share

  25. GUASP M, Gine-Serven E, Maudes E, Rosa-Justicia M, et al
    Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
    Neurology. 2021;97:e61-e75.
    >> Share

    Myasthenia Gravis: Which Type of Surgery Is Best?
    Neurology. 2021;97:e433-e435.
    >> Share

    PLoS One

  27. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    >> Share

  28. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    >> Share

    Proc Natl Acad Sci U S A

  29. JUUL-MADSEN K, Troldborg A, Wittenborn TR, Axelsen MG, et al
    Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016